Clinical Trial Update: Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival [Phase 4]

View source ↗

Summary

Phase 4 study that develops and validates a prognostic score to identify metastatic breast cancer patients who are most likely to benefit from a third-line chem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Metastatic Breast Cancer Starting a Third Line Chemotherapy | Phase 4 | Status: COMPLETED